Dongkook Pharmaceutical Launches 'Sarapenplaster Joint,' the First Joint-Specific Patch Available at Pharmacies

Stable Adherence Even on Flexed Areas

Dongkook Pharmaceutical announced on November 26 that it has launched 'Sarapenplaster Joint,' the first joint-specific patch available at pharmacies.

Joint-specific patch 'Sarapenplaster Joint'. Dongkook Pharmaceutical

Sarapenplaster Joint features a cross-shaped design to ensure it adheres securely to highly mobile joint areas without easily coming off. It contains 60 mg of the main ingredient, ketoprofen, which allows for high skin permeability and rapid absorption, delivering powerful anti-inflammatory and analgesic effects.

In particular, by applying the Transdermal Drug Delivery System (TDDS) technology, the medication quickly reaches the targeted local area, providing fast pain relief. As a result, the therapeutic effect lasts for 24 hours, making it economical and efficient to use just one patch per day.

Additionally, when the central circular guide is aligned with the center of the knee pain area, the patch wraps around the joint and adheres closely, maintaining stability even on flexed areas. For younger individuals, it can be widely used as a pain care product after sports activities, while for middle-aged and older adults-who need to pay special attention to joint care during winter activities such as preparing kimchi-it serves as an essential daily item.

A Dongkook Pharmaceutical representative stated, "With the growing number of people taking up running, there have been around 500 marathon events held this year alone, leading to an increase in cases of knee joint pain. As joints tend to lose flexibility and stiffen in cold weather, we hope that 'Sarapenplaster Joint' will help people maintain vitality in their daily lives."

This content was produced with the assistance of AI translation services.